KYG3224E1061
KYG3224E1061
EVEREST MED
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 1.706.678.000 | 706.678.000 | 141.5% |
| Cost of Revenue | 524.775.000 | 179.794.000 | 191.9% |
| Gross Profit | 1.181.903.000 | 526.884.000 | 124.3% |
| 1.552.571.000 | 1.270.788.000 | 22.2% | |
| Operating Income | -370.668.000 | -743.904.000 | 50.2% |
| Pretax Income | -598.364.000 | -1.041.375.000 | 42.5% |
| Net Income Common Stockholders | -297.766.000 | -1.041.375.000 | 71.4% |
| -- | -- | -- | |
| -- | -- | -- |